Diagnosed with stage 4 pancreatic cancer, Kerrie Watson had few options. Then, Dr. Ardaman Shergill enrolled her in a clinical trial for daraxonrasib—a novel targeted therapy. Today, she is living a normal life. #KRASinhibitors
@uchicagoobgyn.bsky.social
Read more: https://ow.ly/Blt550ZVtmP
